Cargando…

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”

Detalles Bibliográficos
Autores principales:	Periclou, Antonia, Riccobene, Todd, Kapás, Margit, Laszlovszky, István
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717184/ https://www.ncbi.nlm.nih.gov/pubmed/31292862 http://dx.doi.org/10.1007/s40262-019-00795-9

Ejemplares similares

Population Pharmacokinetics of Cariprazine and its Major Metabolites
por: Periclou, Antonia, et al.
Publicado: (2020)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
por: Still, Daniel, et al.
Publicado: (2023)

Clinical pharmacology of atypical antipsychotics: an update
por: Mauri, M.C., et al.
Publicado: (2014)

Unmasking of severe hypertriglyceridaemia associated with antipsychotic therapy by atypical eruptive xanthomas
por: Kiedrowicz, Magdalena, et al.
Publicado: (2017)

Underlying disease may increase mortality risk in users of atypical antipsychotics
por: Li, Zhi-Peng, et al.
Publicado: (2022)

Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania
por: Periclou, Antonia, et al.
Publicado: (2019)

Preferential binding to dopamine D(3) over D(2) receptors by cariprazine in patients with schizophrenia using PET with the D(3)/D(2) receptor ligand [(11)C]-(+)-PHNO
por: Girgis, Ragy R., et al.
Publicado: (2016)

Response to comment on the recently published article “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
por: VandenBerg, Amy M.
Publicado: (2023)

Atypical antipsychotics and delirium in critical care
por: Wise, Matt P, et al.
Publicado: (2011)

Atypical antipsychotics for the treatment of musical hallucinations in an elderly patient without a psychiatric disorder
por: Peritogiannis, Vaios, et al.
Publicado: (2016)

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
por: Laszlovszky, István, et al.
Publicado: (2021)

Comment on: update on the management of overactive bladder
por: Staskin, David
Publicado: (2022)

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman
por: Burad, Jyoti, et al.
Publicado: (2021)

Modafinil Augmentation of Atypical Antipsychotic Agents: Duplicate Publication, Self-plagiarism, Salami Publication, and Other Matters
por: Banwari, Girish, et al.
Publicado: (2016)

Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D(3) Receptors in the Brain in vivo
por: Kiss, Béla, et al.
Publicado: (2022)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
por: Chandler, Rebecca Ellen, et al.
Publicado: (2018)

Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants
por: Standing, Joseph F
Publicado: (2022)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
por: Toja-Camba, Francisco José, et al.
Publicado: (2021)

Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
por: Liu, Zheng, et al.
Publicado: (2022)

Clinical perspective on antipsychotic receptor binding affinities
por: Crapanzano, Calogero, et al.
Publicado: (2021)

An Update on the Management of Diabetic Neuropathic Pain: A Few Comments
por: Ghobadifar, Mohamed Amin
Publicado: (2015)

Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II”
por: Völler, Swantje, et al.
Publicado: (2021)

Gender differences in the use of atypical antipsychotic medications for ICU delirium
por: Karamchandani, Kunal, et al.
Publicado: (2018)

Comment on “An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”
por: Rege, Bhaskar, et al.
Publicado: (2022)

Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
por: Bonnet, Udo, et al.
Publicado: (2021)

Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”
por: Piena, Marjanne A., et al.
Publicado: (2022)

Comment on gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions
por: Akbulut, Sami, et al.
Publicado: (2021)

Antipsychotics and OCD: Boon or Bane?
por: Naguy, Ahmed
Publicado: (2017)

Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
por: Gibbons, Jacqueline A.
Publicado: (2015)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Response to: Comment on 'Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay'
por: McNally, R J Q, et al.
Publicado: (2015)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Comment on "Atypical Epidemiologic Finding in Association between Depression and Alcohol Use or Smoking in Korean Male: Korean Longitudinal Study of Aging"
por: Kawada, Tomoyuki
Publicado: (2015)

Comment on “Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis”
por: Chu, Jiang-Tao
Publicado: (2020)

Comment on ‘Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety’
por: Koren, Andrew, et al.
Publicado: (2021)

Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects”
por: Xie, Ran, et al.
Publicado: (2019)

Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”
por: Cattaneo, Dario, et al.
Publicado: (2021)

Authors’ Reply to Ganijee et al.: “Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults”
por: Boettcher, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9f1o19930a0cggn5vqvea8rjhv